Relationship between COVID-19 vaccine hesitancy and willingness to pay for the booster dose of COVID-19 vaccine of oncology patients in Taizhou, China

References

• Nugent MA. The future of the COVID-19 pandemic: how good (or bad) can the SARS-CoV2 spike protein get? Cells. 2022;11(5):855.
   PubMed Web of Science ®Google Scholar
• Vitiello A, Ferrara F, Troiano V, et al. COVID-19 vaccines and decreased transmission of SARS-CoV-2. Inflammopharmacology. 2021;29(5):1357–1360.
   PubMed Web of Science ®Google Scholar
• National Health Commission of the People’s Republic of China. Prevention and control of COVID-19 epidemic situation. Available online: http://www.nhc.gov.cn/xcs/fkdt/202112/72c7929f82d541c89d846d8a67f35995.shtml
   Google Scholar
• Cho SI, Yoon S, Lee HJ. Impact of comorbidity burden on mortality in patients with COVID-19 using the Korean Health insurance database. Sci Rep. 2021;11(1):6375.
   PubMed Web of Science ®Google Scholar
• Guan WJ, Liang WH, Zhao Y, et al. Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis. Eur Respir J. 2020;55(5):2000547.
   PubMed Web of Science ®Google Scholar
• Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–249.
   PubMed Web of Science ®Google Scholar
• Kuderer NM, Choueiri TK, Shah DP, COVID-19 and Cancer Consortium, et al. Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study. Lancet. 2020;395(10241):1907–1918.
   PubMed Web of Science ®Google Scholar
• Horn L, Garassino M. COVID-19 in patients with cancer: managing a pandemic within a pandemic. Nat Rev Clin Oncol. 2021;18(1):1–2.
   PubMed Web of Science ®Google Scholar
• Dai M, Liu D, Liu M, et al. Patients with cancer appear more vulnerable to SARS-CoV-2: a multicenter study during the COVID-19 outbreak. Cancer Discov. 2020;10(6):783–791.
   PubMed Web of Science ®Google Scholar
• European Society of Medical Oncology. ESMO statements for vaccination against COVID-19 in patients with cancer. Available online: https://www.esmo.org/covid-19-and-cancer/covid-19-vaccination.
   Google Scholar
• American Society of Clinical Oncology. COVID-19 vaccines & patients with cancer. Available online: https://www.asco.org/ asco-coronavirus-resources/covid-19-vaccines-patients-cancer.
   Google Scholar
• National Comprehensive Cancer Network. Recommendations of the NCCN COVID-19 Vaccination Advisory Committee. Available online: https://www.nccn.org/docs/default-source/covid-19/2021_covid-19_vaccination_guidance_v2-0.pdf.
   Google Scholar
• Pappas G, Saloustros E, Boutis A, et al. Vaccine third dose and cancer patients: necessity or luxury? ESMO Open. 2021;6(6):100306.
   PubMedGoogle Scholar
• Re D, Seitz-Polski B, Brglez V, et al. Humoral and cellular responses after a third dose of SARS-CoV-2 BNT162b2 vaccine in patients with lymphoid malignancies. Nat Commun. 2022;13(1):864.
   PubMed Web of Science ®Google Scholar
• Shroff RT, Chalasani P, Wei R, et al. Immune responses to two and three doses of the BNT162b2 mRNA vaccine in adults with solid tumors. Nat Med. 2021;27(11):2002–2011.
   PubMed Web of Science ®Google Scholar
• Lin Y, Hu Z, Zhao Q, et al. Understanding COVID-19 vaccine demand and hesitancy: a nationwide online survey in China. PLoS Negl Trop Dis. 2020;14(12):e0008961.
   PubMed Web of Science ®Google Scholar
• Das U, Rathore U, Pal R. On willingness to pay for covid-19 vaccines: a case study from India. Hum Vaccin Immunother. 2021;17(12):4904–4913.
   PubMed Web of Science ®Google Scholar
• Karam MM, Baki JA, Al-Hajje A, et al. Willingness to pay for a coronavirus vaccine and its associated determinants in Lebanon. Value Health Reg Issues. 2022;30:18–25.
   PubMedGoogle Scholar
• MacDonald NE, SWGoV H, SAGE Working Group on Vaccine Hesitancy Vaccine hesitancy: definition, scope and determinants. Vaccine. 2015;33(34):4161–4164.
   PubMed Web of Science ®Google Scholar
• Vergara RJD, Sarmiento PJD, Lagman JDN. Building public trust: a response to COVID-19 vaccine hesitancy predicament. J Public Health. 2021;43(2):e291–e292.
   Google Scholar
• Kang H. Sample size determination and power analysis using the G*power software. J Educ Eval Health Prof. 2021;18:17.
   PubMed Web of Science ®Google Scholar
• Cohen, J. (1992). Statistical Power Analysis. In Current Directions in Psychological Science, Vol. 1, issue 3, pp. 98–101. https://doi.org/10.1111/1467-8721.ep10768783
   Google Scholar
• Tung TH, Lin XQ, Chen Y, et al. Why do parents willingness-to-pay to vaccinate their children against COVID-19? A real-world evidence in Taizhou, China. Hum Vaccin Immunother. 2022;18(1):1–9.
   PubMed Web of Science ®Google Scholar
• Tung TH, Lin XQ, Chen Y, et al. Willingness-to-pay for a booster dose of inactivated SARS-CoV-2 vaccine in Taizhou, China. Hum Vaccin Immunother. 2022;18(6):2099210.
   Web of Science ®Google Scholar
• Wang J, Lyu Y, Zhang H, et al. Willingness to pay and financing preferences for COVID-19 vaccination in China. Vaccine. 2021;39(14):1968–1976.
   PubMed Web of Science ®Google Scholar
• Tung TH, Lin XQ, Chen Y, et al. Willingness to receive a booster dose of inactivated coronavirus disease 2019 vaccine in Taizhou, China. Expert Rev Vaccines. 2022;21(2):261–267.
   PubMed Web of Science ®Google Scholar
• Barriere J, Gal J, Hoch B, et al. Acceptance of SARS-CoV-2 vaccination among French patients with cancer: a cross-sectional survey. Ann Oncol. 2021;32(5):673–674.
   PubMed Web of Science ®Google Scholar
• Di Noia V, Renna D, Barberi V, et al. The first report on coronavirus disease 2019 (COVID-19) vaccine refusal by patients with solid cancer in Italy: early data from a single-institute survey. Eur J Cancer. 2021;153:260–264.
   PubMed Web of Science ®Google Scholar
• Brodziak A, Sigorski D, Osmola M, et al. Attitudes of patients with cancer towards vaccinations-results of online survey with special focus on the vaccination against COVID-19. Vaccines (Basel). 2021;9(5):411.
   Google Scholar
• Wang J, Jing R, Lai X, et al. Acceptance of COVID-19 vaccination during the COVID-19 pandemic in China. Vaccines. Vaccines (Basel). 2020;8(3):482.
   Web of Science ®Google Scholar
• Edwards B, Biddle N, Gray M, et al. COVID-19 vaccine hesitancy and resistance: correlates in a nationally representative longitudinal survey of the Australian population. PLOS One. 2021;16(3):e0248892.
   PubMed Web of Science ®Google Scholar
• Harapan H, Wagner AL, Yufika A, et al. Acceptance of a COVID-19 vaccine in southeast Asia: a Cross-Sectional study in Indonesia. Front Public Health. 2020;8:381.
   PubMed Web of Science ®Google Scholar
• Harapan H, Anwar S, Yufika A, et al. Vaccine hesitancy among communities in ten countries in Asia, Africa, and South America during the COVID-19 pandemic. Pathog Glob Health. 2022;116(4):236–243.
   PubMed Web of Science ®Google Scholar
• Dott F, Rosiello SA, Yufika A, et al. Acceptance of COVID-19 vaccination at different hypothetical efficacy and safety levels in ten countries in Asia, Africa, and South America. Narra J. 2021;1(3).
   Google Scholar
• Hong J, Xu XW, Yang J, et al. Knowledge about, attitude and acceptance towards, and predictors of intention to receive the COVID-19 vaccine among cancer patients in Eastern China: a cross-sectional survey. J Integr Med. 2022;20(1):34–44.
   PubMedGoogle Scholar
• Teo CJH, Burns SF, Kawabata M. Developing nutrition knowledge and attitude measures for athletes with the knowledge-attitude-behavior model. Res Q Exerc Sport. 2022;1–8.
   PubMed Web of Science ®Google Scholar
• Dang JZ, Zhu GY, Yang YJ, et al. Clinical characteristics of coronavirus disease 2019 in patients aged 80 years and older. J Integr Med. 2020;18(5):395–400.
   PubMedGoogle Scholar